Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-25-019609

CHIEF OPERATING OFFICER sold 6,667 shares at an average $19.79 ($131,951)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Anish CHIEF OPERATING OFFICER 2025-07-07 Sale 10b5-1 −6,362 $19.75 $125,639 296,947 I: show line 1 in the form
Patel Anish CHIEF OPERATING OFFICER 2025-07-07 Sale 10b5-1 −305 $20.69 $6,312 296,642 I: show line 2 in the form
Open-market sales · 6,667 sh · avg $19.79 · $131,951
Loading xslF345X05/form4-07092025_110738.xml…